• Je něco špatně v tomto záznamu ?

Microbial enzymes as powerful natural anti-biofilm candidates

LA. Al-Madboly, A. Aboulmagd, MA. El-Salam, I. Kushkevych, RM. El-Morsi

. 2024 ; 23 (1) : 343. [pub] 20241223

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002978

Bacterial biofilms pose significant challenges, from healthcare-associated infections to biofouling in industrial systems, resulting in significant health impacts and financial losses globally. Classic antimicrobial methods often fail to eradicate sessile microbial communities within biofilms, requiring innovative approaches. This review explores the structure, formation, and role of biofilms, highlighting the critical importance of exopolysaccharides in biofilm stability and resistance mechanisms. We emphasize the potential of microbial enzymatic approaches, particularly focusing on glycosidases, proteases, and deoxyribonucleases, which can disrupt biofilm matrices effectively. We also delve into the importance of enzymes such as cellobiose dehydrogenase, which disrupts biofilms by degrading polysaccharides. This enzyme is mainly sourced from Aspergillus niger and Sclerotium rolfsii, with optimized production strategies enhancing its efficacy. Additionally, we explore levan hydrolase, alginate lyase, α-amylase, protease, and lysostaphin as potent antibiofilm agents, discussing their microbial origins and production optimization strategies. These enzymes offer promising avenues for combating biofilm-related challenges in healthcare, environmental, and industrial settings. Ultimately, enzymatic strategies present environmentally friendly solutions with high potential for biofilm management and infection control.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002978
003      
CZ-PrNML
005      
20250206104006.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12934-024-02610-y $2 doi
035    __
$a (PubMed)39710670
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Al-Madboly, Lamiaa A $u Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt. lamia.youssif@pharm.tanta.edu.eg
245    10
$a Microbial enzymes as powerful natural anti-biofilm candidates / $c LA. Al-Madboly, A. Aboulmagd, MA. El-Salam, I. Kushkevych, RM. El-Morsi
520    9_
$a Bacterial biofilms pose significant challenges, from healthcare-associated infections to biofouling in industrial systems, resulting in significant health impacts and financial losses globally. Classic antimicrobial methods often fail to eradicate sessile microbial communities within biofilms, requiring innovative approaches. This review explores the structure, formation, and role of biofilms, highlighting the critical importance of exopolysaccharides in biofilm stability and resistance mechanisms. We emphasize the potential of microbial enzymatic approaches, particularly focusing on glycosidases, proteases, and deoxyribonucleases, which can disrupt biofilm matrices effectively. We also delve into the importance of enzymes such as cellobiose dehydrogenase, which disrupts biofilms by degrading polysaccharides. This enzyme is mainly sourced from Aspergillus niger and Sclerotium rolfsii, with optimized production strategies enhancing its efficacy. Additionally, we explore levan hydrolase, alginate lyase, α-amylase, protease, and lysostaphin as potent antibiofilm agents, discussing their microbial origins and production optimization strategies. These enzymes offer promising avenues for combating biofilm-related challenges in healthcare, environmental, and industrial settings. Ultimately, enzymatic strategies present environmentally friendly solutions with high potential for biofilm management and infection control.
650    12
$a biofilmy $x účinky léků $7 D018441
650    _2
$a Bacteria $x účinky léků $x enzymologie $7 D001419
650    _2
$a Aspergillus niger $x enzymologie $7 D001234
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a glykosidhydrolasy $x metabolismus $7 D006026
650    _2
$a karbohydrátdehydrogenasy $x metabolismus $7 D002237
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Aboulmagd, Asmaa $u Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt
700    1_
$a El-Salam, Mohamed Abd $u Department of Pharmacognosy, Faculty of Pharmacy, Delta University for Science and Technology, International Coastal Road, Gamasa, 11152, Egypt $u School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 VN51, Ireland
700    1_
$a Kushkevych, Ivan $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 62500, Czech Republic
700    1_
$a El-Morsi, Rasha M $u Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, International Coastal Road, Gamasa, 11152, Egypt
773    0_
$w MED00008244 $t Microbial cell factories $x 1475-2859 $g Roč. 23, č. 1 (2024), s. 343
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39710670 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104002 $b ABA008
999    __
$a ok $b bmc $g 2263027 $s 1238985
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 23 $c 1 $d 343 $e 20241223 $i 1475-2859 $m Microbial cell factories $n Microb Cell Fact $x MED00008244
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace